Title : TLK2 enhances aggressive phenotypes of glioblastoma cells through the activation of SRC signaling pathway.

Pub. Date : 2019

PMID : 30207834






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 SRC pathway inhibition by Saracatinib resulted in reduced TLK2-mediated glioblastoma migration, invasion, confirming a key role for SRC signaling in regulating the functions of TLK2. saracatinib SRC proto-oncogene, non-receptor tyrosine kinase Homo sapiens